Literature DB >> 20208150

Structural implications of a G170R mutation of alanine:glyoxylate aminotransferase that is associated with peroxisome-to-mitochondrion mistargeting.

Snezana Djordjevic1, Xiaoxuan Zhang, Mark Bartlam, Sheng Ye, Zihe Rao, Christopher J Danpure.   

Abstract

In a subset of patients with the hereditary kidney-stone disease primary hyperoxaluria type 1 (PH1), the liver-specific enzyme alanine:glyoxylate aminotransferase (AGT) is mistargeted from peroxisomes to mitochondria. This is a consequence of the combined presence of the common P11L polymorphism and a disease-specific G170R mutation. In this paper, the crystal structure of mutant human AGT containing the G170R replacement determined at a resolution of 2.6 A is reported. The crystal structure of AGT consists of an intimate dimer in which an extended N-terminal segment of 21 amino acids from one subunit wraps as an elongated irregular coil around the outside of the crystallographic symmetry-related subunit. In addition to the N-terminal segment, the monomer structure contains a large domain of 261 amino acids and a small C-terminal domain of 110 amino acids. Comparison of the mutant AGT structure and that of wild-type normal AGT shows that the two structures are almost identical, with a backbone-atom r.m.s. deviation of 0.34 A. However, evidence of significant local structural changes in the vicinity of the G170R mutation might be linked to the apparent decrease in protein stability.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20208150      PMCID: PMC2833026          DOI: 10.1107/S1744309109054645

Source DB:  PubMed          Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun        ISSN: 1744-3091


  15 in total

1.  Improved methods for building protein models in electron density maps and the location of errors in these models.

Authors:  T A Jones; J Y Zou; S W Cowan; M Kjeldgaard
Journal:  Acta Crystallogr A       Date:  1991-03-01       Impact factor: 2.290

2.  Crystallography & NMR system: A new software suite for macromolecular structure determination.

Authors:  A T Brünger; P D Adams; G M Clore; W L DeLano; P Gros; R W Grosse-Kunstleve; J S Jiang; J Kuszewski; M Nilges; N S Pannu; R J Read; L M Rice; T Simonson; G L Warren
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1998-09-01

3.  Effect of N-terminal alpha-helix formation on the dimerization and intracellular targeting of alanine:glyoxylate aminotransferase.

Authors:  M J Lumb; A F Drake; C J Danpure
Journal:  J Biol Chem       Date:  1999-07-16       Impact factor: 5.157

4.  Functional synergism between the most common polymorphism in human alanine:glyoxylate aminotransferase and four of the most common disease-causing mutations.

Authors:  M J Lumb; C J Danpure
Journal:  J Biol Chem       Date:  2000-11-17       Impact factor: 5.157

5.  Identification of mutations associated with peroxisome-to-mitochondrion mistargeting of alanine/glyoxylate aminotransferase in primary hyperoxaluria type 1.

Authors:  P E Purdue; Y Takada; C J Danpure
Journal:  J Cell Biol       Date:  1990-12       Impact factor: 10.539

6.  Inhibition of alanine:glyoxylate aminotransferase 1 dimerization is a prerequisite for its peroxisome-to-mitochondrion mistargeting in primary hyperoxaluria type 1.

Authors:  J M Leiper; P B Oatey; C J Danpure
Journal:  J Cell Biol       Date:  1996-11       Impact factor: 10.539

Review 7.  Therapeutic approaches to protein-misfolding diseases.

Authors:  Fred E Cohen; Jeffery W Kelly
Journal:  Nature       Date:  2003-12-18       Impact factor: 49.962

8.  Mistargeting of peroxisomal L-alanine:glyoxylate aminotransferase to mitochondria in primary hyperoxaluria patients depends upon activation of a cryptic mitochondrial targeting sequence by a point mutation.

Authors:  P E Purdue; J Allsop; G Isaya; L E Rosenberg; C J Danpure
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-01       Impact factor: 11.205

Review 9.  Molecular aetiology of primary hyperoxaluria and its implications for clinical management.

Authors:  Christopher J Danpure; Gill Rumsby
Journal:  Expert Rev Mol Med       Date:  2004-01-09       Impact factor: 5.600

10.  An enzyme trafficking defect in two patients with primary hyperoxaluria type 1: peroxisomal alanine/glyoxylate aminotransferase rerouted to mitochondria.

Authors:  C J Danpure; P J Cooper; P J Wise; P R Jennings
Journal:  J Cell Biol       Date:  1989-04       Impact factor: 10.539

View more
  6 in total

1.  Four of the most common mutations in primary hyperoxaluria type 1 unmask the cryptic mitochondrial targeting sequence of alanine:glyoxylate aminotransferase encoded by the polymorphic minor allele.

Authors:  Sonia Fargue; Jackie Lewin; Gill Rumsby; Christopher J Danpure
Journal:  J Biol Chem       Date:  2012-12-10       Impact factor: 5.157

2.  Molecular requirements for peroxisomal targeting of alanine-glyoxylate aminotransferase as an essential determinant in primary hyperoxaluria type 1.

Authors:  Krisztián Fodor; Janina Wolf; Ralf Erdmann; Wolfgang Schliebs; Matthias Wilmanns
Journal:  PLoS Biol       Date:  2012-04-17       Impact factor: 8.029

Review 3.  Protein homeostasis defects of alanine-glyoxylate aminotransferase: new therapeutic strategies in primary hyperoxaluria type I.

Authors:  Angel L Pey; Armando Albert; Eduardo Salido
Journal:  Biomed Res Int       Date:  2013-07-16       Impact factor: 3.411

4.  The role of protein denaturation energetics and molecular chaperones in the aggregation and mistargeting of mutants causing primary hyperoxaluria type I.

Authors:  Noel Mesa-Torres; Israel Fabelo-Rosa; Debora Riverol; Cristina Yunta; Armando Albert; Eduardo Salido; Angel L Pey
Journal:  PLoS One       Date:  2013-08-27       Impact factor: 3.240

5.  Ras-activated RSK1 phosphorylates EBP50 to regulate its nuclear localization and promote cell proliferation.

Authors:  Hooi Cheng Lim; Tzuu-Shuh Jou
Journal:  Oncotarget       Date:  2016-03-01

6.  Structural dynamics shape the fitness window of alanine:glyoxylate aminotransferase.

Authors:  Mirco Dindo; Stefano Pascarelli; Davide Chiasserini; Silvia Grottelli; Claudio Costantini; Gen-Ichiro Uechi; Giorgio Giardina; Paola Laurino; Barbara Cellini
Journal:  Protein Sci       Date:  2022-05       Impact factor: 6.725

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.